ELI LILLY & COMPANY LTD — UK Government Contract Awards

Basingstoke, UKJ37, GB

Procurements won

Awards

Distinct buyers

Awarded GBP value

£0

Published organisation identifiers

GB-FTS-106070GB-FTS-121951GB-FTS-145627GB-FTS-148937GB-FTS-23256GB-FTS-23574GB-FTS-28657GB-FTS-5074GB-FTS-58907GB-FTS-61102GB-FTS-6427GB-FTS-7262GB-FTS-77516GB-FTS-89598GB-PPON:PTTR-3628-HTTN

Recent awards

Award / procedure	Buyer	Awarded	Award value
Lot 1 - CM/PHR/25/5730/01 - NHS Branded Medicines Tranche A for Midlands & East	NHS England	15 Jun 2026, 00:00 BST	£665,389,588
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026	NHS England	Not published	Not published
Proprietary Drugs	eTenderwales	Not published	Not published
NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025	NHS England	Not published	Not published
Biologic and Biosimilar Medicines	eTenderwales	Not published	Not published
CA02825 Ixekizumab (Taltz®)	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Not published	Not published
NHS Framework for Branded Medicines - London & South of England - Lot 2	NHS England	Not published	Not published
NHS Framework for Branded Medicines - London & South of England	NHS England	Not published	Not published
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024	NHS England	Not published	Not published
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)	NHS England	Not published	Not published